Literature DB >> 11834094

Factors associated with the temporomandibular disorder, pain dysfunction syndrome (PDS): Manchester case-control study.

T V Macfarlane1, J Kincey, H V Worthington.   

Abstract

OBJECTIVES: To determine the individual and combined effects of potential risk factors in relation to the temporomandibular disorder, Pain Dysfunction Syndrome (PDS).
DESIGN: Case-control study.
MATERIAL AND METHODS: Cases were new referrals to the temporomandibular disorder clinic of the University Dental Hospital of Manchester, diagnosed with PDS. Controls were randomly selected from 24 dental practices. Using a postal questionnaire information was collected on socio-demographic, local mechanical, psychological factors, co-morbidities and illness behaviour. The adjusted participation rate was similar in cases and controls (64%), and 131 cases and 196 controls finally participated in the study.
RESULTS: Compared with the controls, the cases were more likely to report that their teeth felt as though they did not fit together properly [odds ratio (OR) 8, 95% Confidence Interval (CI) 6-13] and report history of facial trauma (OR 3, 95% CI 2-6). Both diurnal and nocturnal grinding were significantly associated with PDS, and individuals who reported grinding their teeth both during the day and at night had a risk of 6; 95% CI 3-13 for PDS compared with those who did not. A history of orthodontic treatment, having any dentures, having missing teeth, use of chewing gum or biting the fingernails did not show any relationship with PDS. People who took medication for the bowels had a higher risk of PDS (OR 2, 95% CI 1-4). Participants with frequent headaches had a threefold increase in risk of having PDS (OR 3, 95% CI 2-5) while having pain in parts of the body other than the head was associated with an OR of 3 (95% CI 2-5). An increased propensity to have PDS was seen in those individuals with higher levels of psychological distress (OR 3; 95% CI 1-4 in the highest category, test for trend P < 0.001) and sleep disturbance (OR 5; 95% CI 2-94 in the highest category, test for trend P < 0.001). Aspects of illness behaviour, such as disease conviction (OR 4; 95% CI 2-9 in the highest category) and perception of illness (0.3; 95% CI 0.2-0.5) were associated with PDS. The result for the denial scale became statistically significant after adjustment for age and gender (2; 95% CI 1-3).
CONCLUSIONS: The current case-control study provides complementary epidemiological information on oro-facial pain (OFP) and supports a multifactorial aetiology of PDS, with factors from many domains, including local mechanical factors, psychological and co-morbidities. People with PDS were characterized by frequent headaches, history of facial trauma, teeth grinding, sleep problems, pain elsewhere in the body and high levels of psychological distress. From the results of current study and available evidence it seems inappropriate to consider PDS in isolation and future research should adopt a multidisciplinary approach to OFP.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11834094     DOI: 10.1034/j.1601-0825.2001.00758.x

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  11 in total

1.  Correlating cone beam CT results with temporomandibular joint pain of osteoarthritic origin.

Authors:  G Palconet; J B Ludlow; D A Tyndall; P F Lim
Journal:  Dentomaxillofac Radiol       Date:  2011-11-24       Impact factor: 2.419

2.  ID migraine questionnaire in temporomandibular disorders with craniofacial pain: a study by using a multidisciplinary approach.

Authors:  Carlo Di Paolo; Anna Di Nunno; Nicola Vanacore; Gianluca Bruti
Journal:  Neurol Sci       Date:  2009-06-03       Impact factor: 3.307

3.  Development of temporomandibular disorders is associated with greater bodily pain experience.

Authors:  Pei Feng Lim; Shad Smith; Kanokporn Bhalang; Gary D Slade; William Maixner
Journal:  Clin J Pain       Date:  2010-02       Impact factor: 3.442

4.  Sleep disorders and their association with laboratory pain sensitivity in temporomandibular joint disorder.

Authors:  Michael T Smith; Emerson M Wickwire; Edward G Grace; Robert R Edwards; Luis F Buenaver; Stephen Peterson; Brendan Klick; Jennifer A Haythornthwaite
Journal:  Sleep       Date:  2009-06       Impact factor: 5.849

5.  Psychological factors associated with development of TMD: the OPPERA prospective cohort study.

Authors:  Roger B Fillingim; Richard Ohrbach; Joel D Greenspan; Charles Knott; Luda Diatchenko; Ronald Dubner; Eric Bair; Cristina Baraian; Nicole Mack; Gary D Slade; William Maixner
Journal:  J Pain       Date:  2013-12       Impact factor: 5.820

Review 6.  Self-Reported Facial Pain in UK Biobank Study: Prevalence and Associated Factors.

Authors:  Tatiana V Macfarlane; Marcus Beasley; Gary J Macfarlane
Journal:  J Oral Maxillofac Res       Date:  2014-10-01

7.  Temporal relationship between dysthymia and temporomandibular disorder: a population-based matched case-control study in Taiwan.

Authors:  Shang-Lun Lin; Shang-Liang Wu; Shun-Yao Ko; Ching-Yu Yen; Wei-Fan Chiang; Jung-Wu Yang
Journal:  BMC Oral Health       Date:  2017-02-01       Impact factor: 2.757

8.  Identifying potential predictors of pain-related disability in Turkish patients with chronic temporomandibular disorder pain.

Authors:  Meltem Ozdemir-Karatas; Kadriye Peker; Ali Balık; Omer Uysal; Erman B Tuncer
Journal:  J Headache Pain       Date:  2013-03-14       Impact factor: 7.277

9.  Prevalence of temporomandibular disorder in children and adolescents from public schools in southern portugal.

Authors:  Beatriz Minghelli; Iara Cardoso; Melani Porfírio; Roberta Gonçalves; Sabina Cascalheiro; Vera Barreto; Andreia Soeiro; Leandro Almeida
Journal:  N Am J Med Sci       Date:  2014-03

10.  Dysthymia increases the risk of temporomandibular disorder: A population-based cohort study (A STROBE-Compliant Article).

Authors:  Shang-Lun Lin; Shang-Liang Wu; Shun-Yao Ko; Ching-Hsiang Lu; Diew-Wei Wang; Ren-Jy Ben; Chi-Ting Horng; Jung-Wu Yang
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.